SFS will invest USD 35 million in China over the next two years as part of its expansion plan and in order to consolidate some of SFS Group’s operations in China.
SFS achieved solid organic growth of 5.9% in its core business and increased its profitability significantly to 14.4% (adjusted EBITA margin).
Driven by solid sales growth of 5.9% in its core businesses, SFS Group generated consolidated sales of CHF 1,437 million in its 2016 financial year.
SFS is investing approximately CHF 36 million through mid-2018 to increase capacity and productivity at major sites in Switzerland.
The acquisition of Tegra Medical announced on 14 November 2016 was completed on 30 November 2016.
SFS intec AG
T +41 71 727 62 62
F +41 71 727 53 07
67 Ubi Avenue 1
#02-10 Starhub Green
9 Forge Park
US-MA 02038 Franklin
Distributors and partners
Turn ideas into reality
Copyright © 2017 SFS intec - all rights reserved.